INTRODUCTION
Recent studies from this laboratory have demonstrated the existence of a low molecular weight fraction of sera from patients with far-advanced chronic renal disease that inhibits solute transport in vitro in two different systems. The active fraction, which was obtained by gel filtration, inhibited the uptake of para-aminohippurate This work was presented in part at the 83rd Annual Meeting of the Association of American Physicians, 6 May 1970 (Trans. Ass. Amer. Physicians Philadelphia. 83 (PAH)' by rabbit kidney cortical slices (1) and it decreased the short-circuit current of the frog skin and toad bladder (2) . The comparable fraction of normal sera inhibited PAH uptake and decreased short-circuit current infrequently; the difference between the effects of normal vs. uremic fractions was highly significant for both systems. Because PAH uptake by kidney slices is a sodium-dependent function which is inhibited by inhibition of sodium transport2 and the short-circuit current across the anuran membrane is a measure of transepithelial sodium transport, the foregoing studies point to the presence of a circulating inhibitor of sodium transport in patients with chronic uremia. In the present studies, we have examined the effects of the same gel filtration fraction of uremic serum on sodium excretion by the rat. Control studies were performed using the serum fraction from normal subjects or equal volumes of isotonic saline.
METHODS
Blood was obtained from the radial artery or antecubital veins of patients with far-advanced chronic renal disease ranging in age from 17 to 62 yr. The endogenous creatinine clearance was less than 12 ml/min in all patients and averaged 5.5 ml/min for the group. None of the patients had congestive heart failure, none was nephrotic, none was on a salt intake in excess of 8-10 g/day and all were judged to be in sodium balance on clinical grounds. None of the patients was being treated with chronic hemodialysis. A detailed drug history was obtained on each patient and only five of the patients were on either diuretics or digitalis glycosides; ' no correlation emerged between the experimental results and the drug intake. lAbbreviations used in this paper: FEN., fractional sodium excretion; GFR, glomerular filtration rate; PAH, para-aminohippurate; UKV, potassium excretion rate; UN.V, sodium excretion rate.
For comparison with the studies performed with the blood from uremic patients, blood samples were obtained from 18 normal subjects (physicians and laboratory personnel) ranging in age from 22 to 42 yr and subsisting on a salt intake of 12 g/day or less. 27 samples were obtained from subjects maintained either on an ad lib. salt intake or a 12 g daily salt intake and 10 samples were obtained from subjects maintained on a 1 g salt intake for 3 days. No statistically significant difference was observed between these groups and the results were pooled for the control data.
The serum samples were prepared and fractionated by column chromatography through Sephadex G-25 in a manner identical with that described previously (2) . 25 ml of serum was applied to individual 2.5 by 95-cm columns and eluted with a solution of 10 mm ammonium acetate (pH 6.8). The effluent solution was divided into fractions as previously described and the fraction containing the inhibitor of PAH uptake by kidney slices and sodium transport by the frog skin was used in the present studies. This fraction which appears in the eluate after the principal peaks of sodium, potassium, and urea was lyophilized. The dried extract from 25 ml of original serum was very small in quantity and was adherent to the walls of the flask after lyophilization. The flask was carefully rinsed with 2.5 ml of distilled water. The resulting solution, whether it was obtained from a uremic patient or from a normal subject, typically contained less than 6 mEq/liter of sodium, 1 mEq/liter of potassium, 10 mEq/liter of ammonium and 6 mg/100 ml of urea (1 mM) . The fractions were stored at -80'C until the day of assay. Just before injection the sodium and potassium concentrations were adjusted to 140 and 4 mEq/liter respectively and the pH was brought to 7 .40.
The majority of assays were performed without the investigator knowing whether the sample being tested was from a uremic patient, a normal subject, or was isotonic saline. In most instances, assays were performed using a single fraction from a single patient or normal subject. However, several experiments including some of the special experiments which required two or more assays with the same material were performed using pooled samples from more than one patient. The latter experiments included: assays in which uremic and nonuremic fractions were administered sequentially to the same animal; examination of the effect of concentrating the fraction 50-fold (rather than the usual 10-fold); examination of the effects on the fraction of incubation with pronase or chymotrypsin; examination of the effects of extraction with isobutanol; and examination of the effects of alkalinization to pH 10.5 and heating. The more concentrated preparations were obtained by pooling several fractions, relyophilizing them, and then dissolving them in a reduced volume of water. Incubation with pronase and chymotrypsin was performed for 45-60 min at room temperature and at a pH of 7.4 using 1 mg of enzyme/ml of fraction. At the completion of the incubation, the samples were boiled for 10 min to destroy the enzyme using a glass tear to prevent loss of fluid by evaporation. The isobutanol extractions were performed at room temperature by adding 3 ml of isobutanol to 2 ml of fraction after acidification with 6 N HCO to pH 1-1.5. Two extractions were performed on each sample. Mixing was accomplished with a Vortex mixer for 45-60 sec and after centrifugation, the organic and aqueous phases were separated. Both were evaporated to dryness in a water bath at 50°C under a stream of 100% nitrogen and the dried samples were reconstituted to the initial volume of 2 ml with distilled water. Both organic and aqueous phases were tested in the assay system. Alkalinization of the fractions to a pH of 10.5 was accomplished using 1 M NaOH. The fractions were incubated at this pH for 45-60 min. boiled for 10 min, and then restored to pH 7.4 with HCL. In all of the foregoing experiments, the sodium and potassium concentrations and the pH of the treated fractions were adjusted before infusion in a routine fashion.
The assays were performed on female Sprague-Dawley rats of the Holtzman strain weighing from 200 to 300 g. Because of evidence in both man (3) and dog (4) suggesting that the sensitivity of the nephrons to a given natriuretic stimulus increases as the nephron population diminishes, the model chosen for these studies was the "stage III" remnant rat (5) . In an initial operation, one kidney was partially infarcted by ligating several of the second and third order branches of the renal artery. A week later, the remaining kidney was removed. The animals were allowed to recover from the second surgical procedure for at least a week. At the time of study glomerular filtration rate (GFR) averaged 0.83 ml/min. The When PAH-14C was used, inulin-3H rather than inulin-'4C was employed. The concentrations of radioactive inulin and PAH in the infusate were adjusted so that the counting rate in the plasma would be at least 20 times background. In initial experiments no other solution was administered. In later experiments, if the rate of urine flow during the equilibration period exceeded the rate of the sustaining infusion by more than 30-40 dul/min, a second infusion of isotonic saline was administered at a rate equal to the difference. The infusion rates were then maintained constant during the entire experiment. All infusions were delivered through the jugular venous catheter.
After an equilibration period of 80±20 min, several control clearance periods ranging from 10 to 20 min in duration were obtained. When two consecutive clearance periods were obtained with less than 10%o variation in urine flow rate, the control phase was terminated and the test solution was administered either intravenously or intra-arterially into the femoral artery' in a volume of no greater than 1 ml.
(In experiments in which the more concentrated fraction of uremic serum was employed, a total volume of as little as 0.2 ml was employed.) The test solutions were infused at a rate of 100 ul/min. The test solutions employed were: (a) the serum fraction from uremic patients; (b) the comparable serum fraction from normal subjects; and (c) isotonic saline. Clearance periods of either 10 or 20 min in duration were then continued for a period of at least 60 min. When 20-min periods were employed, the first experimental period included the 10 min of infusion of the fraction. When 10-min periods were obtained, the experimental collections were started at the completion of the infusion of the test solution. At the end of each urine collection period, the urinary bladder was gently massaged for 1 min to facilitate bladder emptying. If, at any time, evidence of intermittent obstruction to urine flow was observed, any leakage of urine around the catheter was detected during the abdominal massage, or gross hematuria occurred, the experiment was terminated. This happened in less than 15% of experiments.
Blood samples were collected every 20 min from the femoral arterial catheter or occasionally from the tail when the arterial catheter became occluded. The blood was allowed to flow directly into heparinized microhematocrit tubes. The hematocrit was determined on each sample and the plasma was separated for the determination of inulin and, when indicated, PAH. Sodium and potassium concentrations were determined at the beginning, midpoint and end of each experiment. Because these values remained quite constant, the mean value of the three determinations was used for the calculation of the filtered load of sodium. A Donnan correction factor of 0.95 was employed.
The following prospective criteria were established for the acceptability of an assay: (a) that sodium excretion rates (UNDV) average more than 1 and less than 12 /AEq/ min during the control clearance periods; and (b) that there be no more than 20% change in UNaV in either direction between the penultimate and the final control period. 12 experiments were discarded because they did not satisfy the last criteria. In all studies, the values for GFR, absolute sodium excretion rate, fractional sodium excretion (FEN.), and potassium excretion rate (UKV) after injection of the test solution were compared with the mean values for the last two control periods. The experimental results were collected from three to five consecutive collection periods. The data were analyzed by comparing the control values with both the mean and peak values for the experimental periods obtained during a 50-60 interval after administration of the test solution.
Chemical inulin concentration in plasma and urine was measured using the anthrone method (6) . For the determination of radioactive inulin and PAH in urine and plasma samples, 25-50-Al samples of either undiluted urine or plasma were pipetted into glass counting vials containing 10-15 ml of Bray's solution (7) . The samples were counted in a Packard Tri-Carb liquid scintillation spectrometer (model 3214, Packard Instrument Co., Inc., Downers Grove, Ill.). At least 10,000 counts were obtained for each sample. When 14C and 3H nuclides were present in the same samples, the relative counts due to each isotope were determined with appropriate mixtures of radioactive standards to which 25-50 ' No difference in results was found between the two routes of administration.
Al of "cold" urine or plasma were added. Sodium and potassium were measured using a flame photometer (model 43, Instrumentation Laboratory, Inc., Lexington, Mass.) and the pH of the fractions during their preparation for infusion was measured with a glass electrode. The variation for sets of measurements is expressed as the standard error of the mean. Statistical analysis was performed using Student's t test and significance in the text is expressed as the 2P value.
RESULTS
Two individual studies demonstrating the effects of the serum fractions from a uremic patient and a normal subject on glomerular filtration rate, urine volume, sodium, and potassium excretion of assay animals are shown in Table I . Table IA illustrates the effects of the fraction from a chronically uremic patient. After the surgical procedures had been completed, a period of approximately 3 hr was allowed for the animal to recover from the anesthetic and to achieve a relatively constant rate of urine flow. During the last two control clearance periods, GFR averaged 0.94 ml/min, urine flow 73 Al/min, and UNaV 7.8 AEq/ min. The fraction obtained from 10 ml of uremic serum then was infused intra-arterially in a volume of 1 ml over a 10 min interval at the rate of 100 ,ul/min. During the hour after the start of the infusion, GFR did not change in any consistent direction and urine volume increased modestly. UNaV increased during the first experimental clearance period, reached a peak of 10.4 AEq/min during the third experimental period, and decreased to the control level during the fifth period. FENa rose from a mean value of 5.9% during the last two control periods to a peak value of 8.4% during the third experimental period and then decreased to approximate the control value. UKV did not increase after administration of the serum fraction and the hematocrit remained constant. Table IB depicts the effects of the serum fraction from a normal subject. GFR in the assay animal averaged 1.37 ml/min and UNaV 7.2 /Eq/min during the last two control periods. At the end of the control periods, the fraction was infused intra-arterially over a 10 min interval and observations were made during four consecutive 20-min clearance periods. GFR changed little during the experimental periods and UNNV decreased by a mean 0.5 .Eq/min. FENa changed from a mean control value of 3.7% to a mean value of 3.5% after administration of the fraction. There was a slight decrease in UKV and the hematocrit remained constant.
Representative experiments depicting the effects of normal and uremic fractions in rats with lower GFRs are shown in Table II . After administration of the fraction from a uremic patient (Table IIA) No additional infusion of saline was given in these experiments.
In the second experiment (Table JIB) A representative experiment demonstrating the effects of 1 ml of isotonic saline infused at 100 Al/min on GFR, urine volume, sodium, and potassium excretion is presented in Table III . During the 62 min preinfusion control periods GFR was stable and averaged 1.34 ml/min for the last two control periods. UN.V averaged 4.9 AEq/ min and FEN. 2.6% during the last two control periods. After infusion of saline, GFR increased by a mean of 0.03 and a peak of 0.08 ml/min; UN.V increased by a mean of 0.7 and a peak of 0.9 MEq/min and FEN. increased by a mean of 0.2 and a peak of 0.4%. UKV decreased slightly and hematocrit remained constant.
The results of 42 assays in which the serum fraction from patients with chronic uremia were tested, 37 assays in which the test solution consisted of the serum fraction from normal subjects, and 10 experiments performed with isotonic saline are shown in Tables IV, V . Both values differ significantly from those observed with the normal fractions (P < 0.02). The mean and peak increases in FEN. were 43.0±8.5 and 71.2±13.6% respectively, and both values again are significantly greater than those observed with the normal fractions (P < 0.025).
Table VIII presents the fluid balance (infusion rate(s) minus urine flow) during the control and postinfusion experimental periods in the three groups of assay rats. Urine flow rates during the control periods were comparable in all three groups. All three groups were in slightly negative water balance during both the control and experimental periods; but it is of note that the rats receiving the uremic fraction had the greatest degree of negative balance. Thus, the greater degree of natriuresis observed in the latter group occurred despite net loss of total body water and presumably of extracellular fluid.
The effects of the uremic fractions on sodium excretion did not appear to be related to the volume of fluid in which the fraction was infused. Thus, similar changes in UNaV were observed when the same quantity of uremic fraction was dissolved in 0.2 ml as when the volume of diluent was 1.0 ml. Three experiments (11, 12, and 20) , in which 0.2 ml of a 50-fold concentrated material rather than 1 ml of a 10-fold concentrate was infused, are included in Table IV . In Table IX , eight experiments are shown in which both normal and uremic test solutions were administered sequentially during the course of the same experiment. In the first four experiments, the uremic fraction was administered first and three clearance periods were obtained. Thereafter, the normal material consisting of normal serum fraction in three and isotonic saline in one was administered and three additional clearance periods were obtained. In the other four experiments, the sequence was reversed with the normal fraction (three experiments) or isotonic saline (one experiment) being administered first and the uremic fraction being administered second. In all experiments in which the uremic fraction was administered first, UNaV and FENa decreased after administration of the nonuremic material. In contrast, in all experiments in which the nonuremic solution was administered first, UNaV and FENA increased after infusion of the uremic fraction.
The results of 10 experiments in which both PAH clearance and inulin clearance were measured are shown in Table X . In nine of these experiments, the serum fraction from uremic patients was administered and in one a normal fraction was administered. In seven of the nine experiments with the uremic fraction, a substantial natriuresis ensued; however, in the other two there was no natriuretic response and in tion varied in a random manner which bore no rethe experiment with the normal fraction there was no lationship to the change or lack of change in sodium natriuretic response. PAH clearance and filtration frac-excretion. Results are expressed as in Table IV. 1 ml of serum fraction equivalent to 10 ml original serum was infused at a rate of 100 ul/min in all assays. Results are expressed as in Table IV. 1 ml of isotonic saline was infused at a rate of 100 ;l/min in all assays.
The effects of incubation of uremic fraction with pronase and chymotrypsin are shown in Table XI . Five experiments are shown for each enzyme. With pronase, control experiments were performed with four of the fractions and all produced some natriuresis. In three of these, the same fractions still produced natriuresis after treatment with pronase, while in one (experiment 4) sodium excretion decreased after administration of the pronase-treated fraction. In -the fifth study, no control experiment was performed; but the pronase-treated fraction produced a marked natriuretic response. The results using chymotrypsin were virtually identical with those with pronase. In four of the five studies, natriuresis was produced after injection of the chymotrypsin-treated fractions, while in the fifth experiment sodium excretion decreased. Table XII depicts the effects of extraction of uremic fractions with isobutanol and of incubation at pH 10.5. Four experiments are shown after isobutanol extraction. In two, both aqueous and organic phases were tested and in each the natriuresis produced by the aqueous phase was appreciable while that produced by the organic phase was small in magnitude. In the third experiment, the untreated fraction was tested and then the aqueous phase was examined after isobutanol extraction. The increase in sodium excretion was comparable in both experiments. In the fourth study a control experiment was done first and then isobutanol extraction was performed and the organic phase was tested. Natriuresis was produced by the untreated fraction but sodium excretion decreased after administration of the organic phase of the extracted fraction. One fraction (not shown in the Table) which did not produce natriuresis in the untreated state also was extracted with isobutanol and the aqueous phase was tested. In the control experiment AUN.V averaged Average per cent changes +SE in mean and peak sodium excretion rate (top panel) and mean and peak -fractional sodium excretion (lower panel) obtained during the experimental periods, after infusion of 1 ml isotonic saline (10 experiments), 1 ml serum fraction from normal subjects (37 experiments), and 1 ml serum fraction from patients with chronic uremia (42 experiments). The results were calculated as in Table IV. were incubated at an alkaline pH and then boiled, the natriuretic effect was abolished or markedly decreased. The mean change in UNaV with the unmodified fractions in the control experiments was + 1.96 IEq/min and the mean change in FEN. was + 1.34%. After alkalinization the mean change in UNaV was + 0.27 /sEq/min and FEN. decreased by 0.14% (Table XII) .
DISCUSSION
The present studies were designed to determine whether the same gel filtration fraction of uremic serum that previously has been shown to inhibit PAH uptake by rabbit kidney cortical slices (1) and sodium transport by frog skin and toad bladder (2) would prove to be natriuretic in the rat. Because fractional sodium reab- Fluid balance represents the difference between the infusion rate minus the urine flow rate. Control and experimental periods are defined in Table IV .
Values presented correspond to the same control and experimental periods used in Tables IV,  V, The assay was performed by infusing the equivalent of 10 ml of original uremic serum in a volume of infusate of 1 ml or less into rats weighing from 200 to 300 g. Thus the maximum amount of inhibitor harvested would equal that contained in the original 10 ml volume of serum; but this would presuppose complete recovery with no loss in the fractionation and preparative procedures. If the volume of distribution of the material is that of the extracellular space of the animals, which in a 250 g rat would approximate 50 ml, the amount of natriuretic material administered should have increased the concentration in the recipient animals by no more than 20% of the concentration present in the serum of the donor patient. The fraction from uremic patients proved to be natriuretic with the mean increase in sodium excretion over a 50-60 min period averaging 1.5 sEq/min or 90 /Eq/hr and the peak increase in sodium excretion averaging 2.5 /AEq/min. Fractional sodium Serum fractions from uremic patients were used in all experiments except experiment 10 which was performed with a fraction obtained from a normal subject. The data are presented as in Table IV and the mean changes are shown for the experimental periods.
excretion also increased by an average of 1.4% and a peak of 2.4%. When the comparable fraction of serum from normal subjects was administered, some degree of natriuresis was observed in group data; but the response was significantly greater with the urexmic fractions than with the normal fractions. When 1 ml of isotonic saline was infused under identical experimental conditions, virtually no change in sodium excretion resulted. Moreover, the response produced by the normal fractions was not significantly different from that produced with the saline. The natriuretic response typically began within 10-20 min of administration of the fraction and reached a peak within 40-60 min. When the fraction was concentrated by relyophilization, natriuresis was observed with as little as 0.2 ml of material equivalent to 10 ml of original serum. Moreover, when both uremic fractions and normal fractions or isotonic saline were administered to the same assay animal in random sequence, sodium excretion rate invariably was greater with the uremic fraction than with the normal fraction or isotonic saline.
The reason for using the rat with a reduced nephron population as the assay animal requires some discussion. Theoretically, if the circulating inhibitor in the uremic patients is a natriuretic hormone, or even if it is a toxic substance retained in the blood in uremia, the assay animals should have an increase in the endogenous concen- (8, 9) or blood pressure (10) . Moreover, the increase in sodium excretion rate occurred in the presence of an unchanged or decreased GFR as well as an increased GFR, and there was no correlation between the change in GFR and the change in sodium excretion. Finally neither changes in. PAH clearance nor filtration fractions (11, 12) bore any relationship to the changes in sodium excretion rates.' The basis for the natriuresis, therefore, does not seem to reside in an alteration in the hemodynamic or physical factors (13) that we have been able to measure and, if the natriuretic material is similar to the material which inhibited sodium transport in the anuran membrane, a more likely explanation is that a component step involved in transepithelial sodium transport was affected.
In analyzing the studies done with normal serum fractions, no difference was observed with samples obtained from subjects on a 1 and 12 g salt diet. This could indicate that the factor found in uremic patients is not present or has no physiological significance in normal subjects. Alternatively, if the factor is a natriuretic hormone which is present in the normal state, the activity in subjects on a 12 g salt diet might be too low to be detectable with the present bioassay system. In possible support of the latter view is the fact that in a patient with a GFR of 6 ml/min (the average GFR in the patients studied) on a 7 g salt diet, the requirements for sodium excretion per nephron are equivalent to those that would be obtained in a normal subject (GFR 120 ml/min) ingesting over 120 g of salt per day.
The evidence that the natriuretic material is the same as the fraction of uremic serum previously shown to inhibit sodium transport by frog skin and toad bladder and ' In these experiments we have assumed that the serum fraction had no effect on the renal extraction of PAH in vivo. This may not necessarily be valid, however, in view of the known effects of the uremic fraction on PAH uptake by rabbit kidney cortical slices in vitro (1). The results, therefore, do not rigorously exclude the contribution of a change in filtration fraction to the genesis of the natriuresis. However, this explanation appears unlikely in view of the inhibition of sodium transport by the fraction in the frog skin and toad bladder (2) . Moreover, if the fraction did decrease PAH extraction, thereby obscuring a rise in CPAH, the inhibition of PAH transport would have to have been just enough to offset precisely the true increase in renal plasma flow produced by the fraction. to inhibit PAH uptake by kidney slices is quite substantial. In all three systems, the inhibitor was obtained from a Sephadex G-25 fraction of serum from patients with chronic uremia and the elution characteristics were the same in each instance. The inhibitor thus was contained in the samne fraction. For all three assay systems, the inhibitor or inhibitors resisted boiling, freezing, and digestion with pronase and chymotrypsin (Table XIII) .
Furthermore, extraction of the fraction with an organic solvent was ineffective in removing the inhibitor of PAH uptake by kidney slices (14) and of sodium reabsorption by rat tubules. Using ultrafiltration techniques evidence has been presented which suggests that the inhibitor of sodium transport by the frog skin may have a molecular weight of about 500-1000 (2) ; similar data have not been obtained yet with the rat assay. The present studies suggest that the inhibitor of sodium transport by the nephron is insensitive to incubation at very low pHs, while treatment with alkali at pH 10.5 destroys the activity. Comparable data are not yet available for the other two systems.
Studies currently are in progress to characterize further the chemical nature of the natriuretic material and to define its biologic properties as well as its site of action in the nephron using micropuncture techniques. 
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